Cambridge, United Kingdom

Maria Groves

USPTO Granted Patents = 8 

 

Average Co-Inventor Count = 8.6

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2017-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents

Title: Maria Groves: Innovator in Neurodegenerative Disease Research

Introduction

Maria Groves is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of neurodegenerative diseases, particularly through her innovative research and development of therapeutic antibodies. With a total of 8 patents to her name, her work is paving the way for new treatments for conditions such as Alzheimer's disease.

Latest Patents

Among her latest patents, Maria has developed antibodies that specifically target amyloid beta, a key protein associated with Alzheimer's disease. One of her notable inventions is an antibody that selectively binds to the human amyloid beta 42 peptide over the human amyloid beta 40 peptide. This specificity is crucial for creating effective therapeutic agents aimed at treating conditions related to amyloidosis. Additionally, she has disclosed a method for treating neurodegenerative diseases by administering an anti-cellular prion protein (PrP) antibody. This patent includes antibodies and antigen-binding fragments capable of binding to PrP, along with methods for their production and application.

Career Highlights

Maria Groves is currently associated with Medimmune Limited, where she continues her groundbreaking research. Her work has garnered attention in the scientific community, and she is recognized for her innovative approaches to tackling complex medical challenges.

Collaborations

Maria has collaborated with esteemed colleagues such as Suzanne Gustavsson and Kina Höglund, further enhancing the impact of her research through teamwork and shared expertise.

Conclusion

Maria Groves stands out as a leading inventor in the field of neurodegenerative disease research. Her innovative patents and collaborative efforts are instrumental in advancing therapeutic options for patients suffering from conditions like Alzheimer's disease.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…